Skip to main content

Table 1 Demographics

From: Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

Gender 8 F, 22 M
Age, years 57 (25 to 93)
Baseline pUA, mg/dL 10.8 ± 1.2 (9.0 to 13.7)
Tophi, chronic gout arthritis 28 (93%)
Wt, kg 95.0 ± 31.2 (44 to 203)
BMI 31.5 ± 7.5 (19 to 56)
Serum creatinine, mg/dL 1.9 ± 0.7 (0.8 to 3.2)
Most frequent comorbidities  
Osteoarthritis 4 (13%)
Hypertension 27 (90%)
Diabetes 12 (40%)
Cardiovascular disease 14 (47%)
  1. BMI, body mass index; pUA, plasma urate concentration.